RFS Pharma
Tucker
About RFS Pharma
RFS Pharma, LLC is a clinical-stage biopharmaceutical company founded by Dr. Raymond F. Schinazi to develop new drugs for the treatment of hepatitis infections as well as emerging viruses. Located in a laboratory facility in suburban Atlanta, RFS Pharma will continue to provide growth to the pharmaceutical industry in Georgia. RFS Pharma was incorporated in 2004 and in-licensed anti-hepatitis technology from Emory University in 2013. In addition to its own pipeline, RFS Pharma is actively seeking promising new drugs for in-licensing.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: Less than $1M
- Total funding: $5.0M
- Funding stage: M&A
- Last round: Series Unknown (Dec 2014)
- Website: rfspharma.com
- Phone: (404) 601-1430
Industries & Categories
Biopharma, Biotechnology, Clinical Trials
Social Profiles
Canonical: https://fsome.com/organization/rfs-pharma-972699 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.